APLS - Apellis Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$83.00
DETAILS
HIGH:
$83.00
LOW:
$83.00
MEDIAN:
$83.00
CONSENSUS:
$83.00
UPSIDE:
102.29%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Cooperman | 0 | $0 | -- | -186,853 | SOLD |
| Soros | 0 | $0 | -- | -1,056,000 | SOLD |
| Dalio | 0 | $0 | -- | -34,913 | SOLD |
| Greenblatt | 0 | $0 | -- | -78,750 | SOLD |
| Wood | 0 | $0 | -- | -4,183,918 | SOLD |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-05-14 | DeLong Mark Jeffrey | officer: Chief Business & Strat Officer | D-Return | 18,750 | $44.33 | $831K |
| 2026-05-14 | Chopas James George | officer: VP/Chief Accounting Officer | U-Tender | 65,955 | $0.00 | $6 |
| 2026-05-14 | DeLong Mark Jeffrey | officer: Chief Business & Strat Officer | D-Return | 27,224 | $35.46 | $965K |
| 2026-05-14 | Machiels Alec | director | D-Return | 17,580 | $13.19 | $232K |
| 2026-05-14 | O'Brien Stephanie Monaghan | director | D-Return | 5,748 | $59.86 | $344K |
| 2026-05-14 | O'Brien Stephanie Monaghan | director | D-Return | 8,554 | $47.28 | $404K |
| 2026-05-14 | Dolsten Mikael | director | U-Tender | 14,312 | $4.00 | $57K |
| 2026-05-14 | Sullivan Timothy Eugene | officer: Chief Financial Officer | A-Award | 58,140 | -- | -- |
| 2026-05-14 | Sullivan Timothy Eugene | officer: Chief Financial Officer | A-Award | 41,250 | -- | -- |
| 2026-05-14 | Sullivan Timothy Eugene | officer: Chief Financial Officer | A-Award | 29,070 | -- | -- |
| 2026-05-14 | Sullivan Timothy Eugene | officer: Chief Financial Officer | D-Return | 60,242 | $35.46 | $2.1M |
| 2026-05-14 | Sullivan Timothy Eugene | officer: Chief Financial Officer | U-Tender | 71,492 | $4.00 | $286K |
| 2026-05-14 | Sullivan Timothy Eugene | officer: Chief Financial Officer | D-Return | 43,183 | $52.66 | $2.3M |
| 2026-05-14 | Machiels Alec | director | U-Tender | 150,000 | $0.00 | $15 |
| 2026-05-14 | Machiels Alec | director | D-Return | 3,544 | -- | -- |
| 2026-05-14 | Machiels Alec | director | D-Return | 121,894 | $14.00 | $1.7M |
| 2026-05-14 | Machiels Alec | director | D-Return | 14,684 | $25.12 | $369K |
| 2026-05-14 | Machiels Alec | director | D-Return | 11,199 | $31.91 | $357K |
| 2026-05-14 | Deschatelets Pascal | officer: Chief Scientific Officer | A-Award | 10,030 | -- | -- |
| 2026-05-14 | Deschatelets Pascal | officer: Chief Scientific Officer | D-Return | 110,000 | $14.95 | $1.6M |
| 2026-05-14 | Deschatelets Pascal | officer: Chief Scientific Officer | D-Return | 30,845 | $52.66 | $1.6M |
| 2026-05-14 | Deschatelets Pascal | officer: Chief Scientific Officer | U-Tender | 1,177,222 | $0.00 | $117 |
| 2026-05-14 | Chan Gerald | director | U-Tender | 25,666 | $0.00 | $2 |
| 2026-05-14 | DeLong Mark Jeffrey | officer: Chief Business & Strat Officer | A-Award | 19,006 | -- | -- |
| 2026-05-14 | DeLong Mark Jeffrey | officer: Chief Business & Strat Officer | D-Return | 30,000 | $44.90 | $1.3M |